Skip to main content
Premium Trial:

Request an Annual Quote

Condie Carmack

Condie Carmack has joined GenomOncology as vice president of translational medicine, where he is responsible for the firm's oncology products and services and its newest venture in constitutional medicine. Carmack joins GenomOncology from Vela Diagnostics, where he was director of oncology programs. Before that, he helped form the Cancer Genetics Laboratory at Baylor College of Medicine with Marilyn Li. He was general manager of the lab for two years and previously held positions at Agilent Technologies, Molecular Dynamics, and GenPharm.  

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.